Clinical trial
Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer…
NCT00316407 · Swedish Medical Center, Other · Completed
Key facts
| NCT number | NCT00316407 |
|---|---|
| Title | Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer Patients |
| Official title | Phase I/II Lapatinib Plus Carboplatin and Paclitaxel in Stage III or IV Relapsed Ovarian or Stage IV Breast Cancer Patients |
| Lead sponsor | Swedish Medical Center, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Ovarian Epithelial Cancer Stage III, Stage IV Ovarian Cancer, Stage IV Breast Cancer |
| Intervention type | Drug |
| Interventions | lapatinib (GW572016), Carboplatin, Paclitaxel |
| Enrollment | 30 |
| Start date | Aug 1, 2005 |
| Primary completion | Nov 1, 2009 |
| Completion | Nov 1, 2009 |
| First posted | Apr 20, 2006 |
| Last update posted | Feb 18, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: